CME Session
Hybrid Session
Srinivas R. Viswanathan, MD, PhD
Dana-Farber Cancer Institute
Disclosure: Disclosure(s): Non-CE Consulting: Jnana therapeutics (Terminated, June 25, 2022); MPM Capital (Terminated, June 25, 2022); Vida Ventures (Terminated, June 25, 2022)